#771 on the rich list of 14,644 insiders
Sanj K. Patel
CHAIRMAN & CEO at Kiniksa Pharmaceuticals International.
$244M
in disclosed stock, −$3.9M (−1.59%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 771st of 14,644
- Companies held
- 1
- Largest holding
- KNSA, 100.0% of total
- Latest SEC filing
- Nov 4, 2026
What the $244M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals International KNSA Class A Ordinary Share | The Anglia 2013 Revocable Trust | 951,794 | $93.54 | $89.0M | 36.5% | Form 4, Jun 1, 2026 |
| Kiniksa Pharmaceuticals International KNSA Class A Ordinary Share | Held by The Anglia 2013 Revocable Trust | 774,500 | $93.54 | $72.4M | 29.7% | Form 4, Nov 4, 2026 |
| Kiniksa Pharmaceuticals International KNSA Class B Ordinary Shares | The Anglia 2013 Revocable Trust | 626,160 | $93.54 | $58.6M | 24.0% | Form 4, Jun 1, 2026 |
| Kiniksa Pharmaceuticals International KNSA Class A Ordinary Share | Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016 | 109,795 | $93.54 | $10.3M | 4.2% | Form 4, Nov 4, 2026 |
| Kiniksa Pharmaceuticals International KNSA Class A Ordinary Share | Held by The Patel Family Irrevocable Trust of 2025 | 92,348 | $93.54 | $8.6M | 3.5% | Form 4, Nov 4, 2026 |
| Kiniksa Pharmaceuticals International KNSA Class A Ordinary Share | Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013 | 51,794 | $93.54 | $4.8M | 2.0% | Form 4, Sep 1, 2026 |
Share counts are the amounts Sanj K. Patel reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | Sold | KNSA | 1,460 | $92.35 | $135K | View |
| Nov 4, 2026 | Sold | KNSA | 11,335 | $93.54 | $1.1M | View |
| Nov 4, 2026 | Sold | KNSA | 81,742 | $94.20 | $7.7M | View |
| Nov 4, 2026 | Sold | KNSA | 29,845 | $95.48 | $2.8M | View |
| Nov 4, 2026 | Sold | KNSA | 26,918 | $96.05 | $2.6M | View |
| Nov 3, 2026 | Sold | KNSA | 1,214 | $90.77 | $110K | View |
| Nov 3, 2026 | Sold | KNSA | 68,664 | $92.70 | $6.4M | View |
| Nov 3, 2026 | Sold | KNSA | 145,708 | $93.53 | $13.6M | View |
| Nov 3, 2026 | Sold | KNSA | 4,584 | $94.25 | $432K | View |
| Nov 2, 2026 | Sold | KNSA | 38,364 | $91.03 | $3.5M | View |
| Nov 2, 2026 | Sold | KNSA | 24,188 | $91.83 | $2.2M | View |
| Nov 2, 2026 | Sold | KNSA | 26,781 | $93.06 | $2.5M | View |
| Nov 2, 2026 | Sold | KNSA | 100 | $93.97 | $9K | View |
| Oct 30, 2026 | Sold | KNSA | 41,169 | $92.01 | $3.8M | View |
| Oct 30, 2026 | Sold | KNSA | 18,685 | $92.77 | $1.7M | View |
| Oct 30, 2026 | Sold | KNSA | 15,903 | $93.62 | $1.5M | View |
| Oct 30, 2026 | Sold | KNSA | 8,888 | $94.72 | $842K | View |
| Oct 30, 2026 | Sold | KNSA | 4,490 | $95.97 | $431K | View |
| Oct 30, 2026 | Sold | KNSA | 2,316 | $97.34 | $225K | View |
| Oct 30, 2026 | Sold | KNSA | 1,440 | $98.16 | $141K | View |
| May 1, 2026 | Sold | KNSA | 48,565 | $54.02 | $2.6M | View |
| Apr 30, 2026 | Sold | KNSA | 2,141 | $54.01 | $116K | View |
| Apr 29, 2026 | Sold | KNSA | 22,544 | $54.01 | $1.2M | View |
| Apr 28, 2026 | Sold | KNSA | 51,750 | $54.02 | $2.8M | View |
| Apr 28, 2026 | Sold | KNSA | 243,596 | $52.02 | $12.7M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 768 | Laurence Fink Chairman and CEO, BlackRock. New York, NY | $245M |
| 769 | Scott L. Thompson CEO & PRESIDENT, Somnigroup International. Dallas, TX | $245M |
| 770 | Robert A. Ortenzio Director, Concentra Group Holdings Parent. Addison, TX | $244M |
| 771 | Sanj K. Patel CHAIRMAN & CEO, Kiniksa Pharmaceuticals International | $244M |
| 772 | F. Thomson Leighton Chief Executive Officer, Akamai Technologies. Cambridge, MA | $244M |
| 773 | Howard S. Jonas Chairman, IDT. Newark, NJ | $244M |
| 774 | Jack M. Huynh SVP & GM, Computing & Graphics, Advanced Micro Devices. Santa Clara, CA | $244M |
Other Kiniksa Pharmaceuticals International insiders
All KNSA insiders- John F. Paolini$10.7MCHIEF MEDICAL OFFICER. #8370 overall
- Thomas Malley$8.2MDirector. #9304 overall
- Richard S. Levy$2.1MDirector. #8092 overall
Questions
How much stock does Sanj K. Patel own?
Sanj K. Patel holds $243,788,782 in listed stock based on SEC filings and current prices, mostly Kiniksa Pharmaceuticals International (KNSA). That ranks 771st on the Stock Rich List.
Is this Sanj K. Patel's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Sanj K. Patel last buy or sell stock?
The most recent open-market trade on file is a sale of 1,460 KNSA shares on Nov 4, 2026 at $92.35.